GRFSGrifols SA

Nasdaq grifols.com


$ 9.21 $ 0.80 (9.51 %)    

Wednesday, 11-Sep-2024 15:59:55 EDT
QQQ $ 468.28 $ 9.96 (2.17 %)
DIA $ 409.73 $ 1.01 (0.25 %)
SPY $ 554.79 $ 5.63 (1.03 %)
TLT $ 100.61 $ -0.08 (-0.08 %)
GLD $ 232.25 $ -0.37 (-0.16 %)
$ 9.21
$ 8.81
$ 9.17 x 1,309
$ 9.25 x 1,298
$ 8.81 - $ 9.25
$ 5.30 - $ 12.15
784,237
na
6.33B
$ 0.85
$ 18.95
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 brookfield-in-talks-with-sovereign-funds-to-join-grifols-bid

- Bloomberg

Core News & Articles

- Reuters 

 brookfield-negotiates-over-10b-in-debt-financing-for-acquisition-of-spanish-pharma-giant-grifols

Brookfield Asset Management is reportedly pursuing €9.5 billion in debt financing for a potential take-private deal for Grifols...

 grifols-gigagen-receives-fda-clearance-of-ind-application-for-phase-1-trial-of-recombinant-polyclonal-for-hbv-treatment-giga-2339

GIGA-2339 is the first recombinant polyclonal therapeutic in development to treat and functionally cure chronic hepatitis B vir...

 grifols-new-auditor-discovers-non-cash-accounting-discrepancy-linked-to-china-stake-spanish-company-to-report-adjustment-related-to-china-stake-discrepancy-in-reserves-accounting-found-by-auditor-deloitte---bloomberg-news

https://www.bloomberg.com/news/articles/2024-07-30/grifols-new-auditor-finds-non-cash-accounting-discrepancy-linked-to-china-st...

 grifols-board-votes-to-grant-brookfield-access-to-information-for-potential-takeover-bid-establishes-independent-committee-to-monitor-transaction-progress-and-present-proposals-to-board

- Reuters 

 beleaguered-spanish-drug-firm-grifols-stock-jumps-on-monday---heres-why

Grifols reveals Brookfield Capital's preliminary discussions with major shareholders about a potential joint bid to delist ...

Core News & Articles
Market-Moving News for July 8th
07/08/2024 12:38:38

GRFS: 31% | Brookfield Confirms It Held Exploratory Discussions With Certain Reference Shareholders Of Co In Relation To A Pote...

 brookfield-confirms-it-held-exploratory-discussions-with-certain-reference-shareholders-of-co-in-relation-to-a-potential-joint-offer-for-grifols-shares-to-delist-them

In relation to certain rumors appearing in the media about a potential transaction involving Grifols, S.A. ("Grifols" o...

 grifolss-subsidiary-biotest-forecasts-approximately-1b-in-revenue-from-sales-in-the-us-of-its-intravenous-immunoglobulin-yimmugo-during-the-next-seven-years-following-recent-fda-approval-to-treat-primary-immunodeficiencies

Biotest, a Grifols Group company, is expected to launch its recently FDA-approved intravenous immunoglobulin in the U.S. in f...

 grifols-says-at-end-june-2024-considering-sraas-proceeds-leverage-ratio-is-expected-to-reach-54x-vs-68x-in-march-2024-fcf-in-q2-2024-expected-to-be-positive-contributing-to-reach-5-million-fy24-guidance-which-includes-480-million-of-extraordinary-items-by-end-june-liquidity-will-stand-at-more-than-24-billion-including-sraas-proceeds-is-completely-separate-entity-from-scranton-and-none-of-scrantons-liabilities-are-consolidated-at-cos-group

- Reuters

 grifols-says-16-billion-net-cash-proceeds-from-sale-of-20-equity-stake-in-shanghai-raas-are-currently-deposited-in-cos-bank-account-proceeds-will-be-fully-allocated-to-reduce-2025-senior-secured-notes-and-2027-term-loan-b-and-on-a-pro-rata-basis-as-per-credit-agreement-to-repay-in-full-2025-debt-maturities-leaving-no-additional-maturities-until-2027

- Reuters 

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION